MN-221: Phase II started

By WIR Staff | Jan 1, 2007 | 8:00 AM GMT

MNOV began a placebo-controlled, dose-escalation Phase II trial

Read the full 83 word article

How to gain access

Continue reading with a
two-week free trial.